MGI Tech Co., Ltd. announced that it will introduce many of its latest gene sequencing platforms and sample preparation system at MEDLAB Middle East 2023, taking place 6-9 February in Dubai. Ahead of the event, MGI will host a demonstration of the innovative robotic ultrasound system MGIUS-R3 at Arab Health, taking place from January 30 until 2 February also in Dubai. As one of the sequencers with the fastest speed among those with the same throughput in the world, DNBSEQ-G99 is developed based on MGI's core DNBSEQ sequencing technology.

It for the first time adopts triangular matrix signal spots on sequencing flow cell, among other innovations in biochemistry, optics, fluidics, temperature control and more, reaching higher density of data output, with an overall throughput of 8-48 Gb per run. DNBSEQ-G99 is especially suitable for targeted gene sequencing and small genome sequencing, requiring only 12 hours to finish PE150 sequencing. DNBSEQ-E25, the flagship product in the E-series, is a portable, accessible, and user-friendly sequencer that features a data throughput of up to 7.5G daily.

Built on the newly designed self-luminous biochemical system, DNBSEQ-E25 has upgraded its sequencing system, flowcells and sequencing cartridge. Equipped with built-in bioinformatics, it is designed to run sequencing and generate analysis reports on the go. Its ease of setup means it is ready to run in ten minutes, coupled by a quick turnaround time that takes only 20 hours from sample to FASTQ data.

Lastly, DNBelab-D4 is the first digital microfluidic automation platform developed by MGI. The portable digital sample preparation system can prepare samples from DNA to DNB on a single sample prep card. Meanwhile, it integrates the quantification function for automatic quantification after DNB preparation is completed, eliminating the need for manual quantification.

Currently, DNBelab-D4 is mainly used for library preparation for high-throughput sequencing applications such as metagenomics sequencing of unknown pathogens. It can also cater to the requirements of different research and medical applications. In addition to MEDLAB Middle East, MGI joins healthcare industry leaders and stakeholders at Arab Health and showcases the robotic ultrasound system MGIUS-R3.

Tele-robotic ultrasound is the key tool and up to date technology for traditional ultrasound applying in tele-medicine, enabling patients to enjoy the ultrasound screening service over distance. It played a crucial role in helping front line hospital doctors conduct remote diagnosis during the COVID-19 pandemic and be widely applied among both tele-diagnosis and tele-education. MGI representatives will be present at Arab Health until 2 February and MEDLAB Middle East between 6-9 February.

Those interested in learning more are encouraged to visit MGI's product display and explore how its latest platforms can accommodate various genomic needs.